Ra Capital Management, L.P. Adicet Bio, Inc. Transaction History
Ra Capital Management, L.P.
- $5.82 Billion
- Q3 2025
A detailed history of Ra Capital Management, L.P. transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 7,541,000 shares of ACET stock, worth $4.98 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
7,541,000
Previous 7,541,000
-0.0%
Holding current value
$4.98 Million
Previous $4.6 Million
32.78%
% of portfolio
0.1%
Previous 0.1%
Shares
3 transactions
Others Institutions Holding ACET
# of Institutions
58Shares Held
53.3MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA11.4MShares$7.56 Million0.32% of portfolio
-
Tang Capital Management LLC San Diego, CA8.22MShares$5.43 Million0.3% of portfolio
-
Goldman Sachs Group Inc New York, NY3.75MShares$2.48 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.27MShares$2.16 Million0.0% of portfolio
-
Carlyle Group Inc. Washington, DC2.95MShares$1.95 Million2.99% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $26.4M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...